OBJECTIVE: To review the mechanisms by which leptin, insulin and adiponectin influence lipid metabolism and plasma lipids in obesity, as well as to describe the associations between these hormones in prepubertal children. METHOD: Revision of relevant papers published in the last 5 y related to the interactions of leptin, insulin and adiponectin, with special emphasis on those reporting potential mechanisms by which these hormones regulate lipid metabolism and plasma lipids. We also provide original results concerning the relationships found between plasma lipids and leptin, and insulin and adiponectin in prepubertal obese children. RESULTS: Recent data in the literature shed new light to explain the effects of both leptin and adiponectin in the regulation of lipid metabolism in peripheral tissues. Activation of the AMP-dependent kinase pathway and subsequent increased fatty acid oxidation seems to be the main mechanism of action of these hormones in the regulation of lipid metabolism. In addition, we have found that insulin plasma levels are positively associated to leptin but negatively correlated with adiponectin in obese children. Adiponectin is negatively associated to plasma lipid markers of metabolic syndrome but positively related to HDLcholesterol, whereas insulin and leptin show opposite patterns. These results support the effect of adiponectin in increasing insulin sensitivity and decreasing plasma triglycerides. CONCLUSION: Leptin, insulin and adiponectin are associated hormones that regulate lipid metabolism in childhood. Adiponectin appears to be the missing link to explain the alterations in lipid metabolism and plasma lipids seen in obesity.
Introduction
Obesity is characterized by an altered balance between energy intake and energy expenditure. Energy homeostasis is accomplished through a highly integrated and redundant neurohumoral system that minimizes the impact of short-term fluctuations in energy balance on fat mass. 1 Critical elements of this control system are hormones secreted in proportion to body adiposity, including leptin, insulin and adiponectin, and the central nervous system (CNS) and other peripheral targets upon which they act. Some of these CNS targets stimulate food intake and anabolic pathways, promoting weight gain, whereas others reduce food intake and catabolic pathways, promoting weight loss. 2, 3 Moreover, a number of hormones, including leptin, insulin, adiponectin and catecholamines, regulate the fuel metabolism, that is, lipid metabolism, in a number of peripheral tissues, independently of the regulation of food intake. [4] [5] [6] [7] [8] Obesity is associated to the metabolic syndrome characterized by hyperinsulinemia, glucose intolerance or diabetes type 2 and two or more of the following factors: hypertension, hypertriglyceridemia, decreased plasma levels of HDL-cholesterol (HDL-c), small and dense LDL particles, increased apoprotein B (apo-B), decreased apoprotein A-I (apo-A-I) and alterations of hemostasia. 9 Typical alterations of the metabolic syndrome may begin early in childhood, as they have been reported in prepubertal children 10, 11 and adolescence. 12 However, the etiology of insulin resistance and its associated biochemical alterations, particularly those affecting lipid metabolism, continue to be a matter of debate. Changes in leptin, insulin and adiponectin, associated to obesity and their effects on lipid metabolism, may explain the alterations in plasma lipids and other characteristic features of the metabolic syndrome.
In this study, we briefly review the relationships of leptin, insulin and adiponectin with obesity and particularly in the regulation of lipid metabolism and plasma lipids. We also provide results about the relationships of those hormones with plasma lipids in prepubertal children.
Regulation of lipid metabolism by leptin, insulin and adiponectin
Insulin and leptin are secreted in direct proportion, and adiponectin in negative proportion, to the size of the adipose mass. These three hormones are key molecules in the regulation of lipid metabolism. During states of positive energy balance, as it occurs in obesity, the adipose mass expands and more leptin and insulin 1, 4 but less adiponectin are secreted. 13, 14 Leptin and insulin reach the brain and, as a consequence, anabolic pathways are inhibited and catabolic pathways are activated. These two hormones, as well as adiponectin, also interact with peripheral tissue receptors modulating energy metabolism.
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Leptin: a regulator of excessive energy intake and lipid metabolism Leptin is produced by adipose tissue and considered to be one of the main peripheral signals that regulate food intake, energy expenditure and body weight, by reporting nutritional information to key regulatory centers in the hypothalamus. 15 Leptin exerts complex effects on the storage and metabolism of fats and carbohydrates. These are mediated both directly, through actions on specific tissues, and indirectly, through CNS endocrine and neural mechanisms. 4 Leptin stimulates fatty acid oxidation and glucose uptake and prevents lipid accumulation in non-adipose tissues, which can lead to lipotoxicity and functional impairments. 6 The increase in the expression of uncoupling proteins (UCP) in adipose tissue and muscle, which occurs during leptin treatment may also account for leptin's ability to prevent the decrease in energy expenditure that takes place during the reduction of food intake. 4 Studies involving, intrahypothalamically or intravenously, leptin injection, as well as incubation of soleus muscle or cultured muscle cells with leptin, have demonstrated that leptin stimulates fatty acid oxidation in skeletal muscle by activating (phosphorylating) AMPK. This enzyme potently stimulates fatty acid oxidation in muscle by inhibiting (phosphorylating) acetyl-CoA carboxilase (ACC) activity, which inhibits malonyl-CoA synthesis, activating carnitine palmitoyl transferase 1 (CPT1) activity. 6 Early activation of AMPK occurs by leptin action on muscle, whereas later activation depends on leptin action through the hypothalamic-sympathetic nervous system axis. 18, 19 According to this, leptin inactivates (dephosphorylates) AMPK in the hypothalamus, as well as other anorexigenic compounds, that is, insulin, and C-75. These findings demonstrate that AMPK plays a role not only in the alteration of metabolic pathways in muscle and liver but also in the regulation of feeding, and identify AMPK as a novel target for anti-obesity drugs. 19 Although AMPK inactivation in the hypothalamus is puzzling, this finding could be pointing out to the actual role of diet-induced obesity hyperleptinemia. Weight gain begins when the caloric balance becomes positive, but, ultimately, weight reaches a plateau, indicating that caloric balance has been restored; this equilibrium of caloric intake and expenditure may reflect the action of endogenous hyperleptinemia on the hypothalamus.
20 Figure 1 shows the effects of hyperleptinemia on AMPK in both the hypothalamus and skeletal muscle.
There is a controversy about the direct interaction between leptin and insulin. Apparently, hyperinsulinemia promotes fat deposition, which subsequently increases leptin expression. 5, 17 Leptin has also been suggested to be related to insulin resistance. 21 Moreover, in healthy children and adults, obese individuals or those who have insulin-dependent or non-insulin-dependent diabetes, there is a positive correlation between leptin and insulin concentrations during fasting, independent of body fat content. These results led to the suggestion that leptin might be the signal from adipocytes to islets to hypersecrete insulin when fat content is increased and insulin sensitivity is lowered. 22 However, a great deal of additional information is needed to clarify the relationship between leptin and insulin sensitivity, in both physiological and pathological conditions. It is well known that insulin actions are mainly mediated by phosphatidyl inositol-3-kinase (PI-3K), which influences mitogenesis, glucose uptake by GLUT4 transporter and protein phosphatase, which mainly affects glucogen synthesis and lipogenesis. 23 Since leptin contributes to enhance fatty acid oxidation in muscle, and probably in other tissues, this hormone would counteract the action of insulin, preventing an excess of triglyceride (TG) accumulation in obesity and other related metabolic disorders.
Adiponectin: a link between adiposity, insulin resistance and lipid metabolism Adiponectin is an adipose tissue-derived hormone that has an important role as a modulator of insulin action and exhibits anti-inflammatory and antiatherogenic properties. 24, 25 In humans, adiponectin levels are inversely related to the degree of adiposity and positively associated with insulin sensitivity both in healthy subjects and in diabetic patients. 26 Plasma adiponectin concentrations have been reported to be decreased in some insulin-resistance states, such as obesity and type 2 diabetes mellitus, and also in patients with coronary artery disease. 13 Moreover, plasma levels of adiponectin have been shown to correlate negatively with body mass index, insulin and TG levels, and positively with HDL-c in adult obese subjects. 16 Hormones and plasma lipids M Gil-Campos et al Adiponectin increases insulin sensitivity by enhancing tissue fat oxidation, which results in reduced circulating fatty acid levels and TG contents in liver and muscle. 26 Adiponectin increases the tyrosine kinase activity of insulin receptor by enhancing the activity of the oxidative phosphorylation UCPs. 7 Adiponectin knockout mice fed a carbohydrate-rich diet develop insulin resistance and have a reduced PI-3K activity. 27 In addition, adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPK. 7, 8, 28 Thus, the administration of either globular adiponectin or the complete adipokine to mice increases the AMPK-dependent phosphorylation in skeletal muscle; in the liver, this activation only occurs when the complete form of the hormone is injected. 7 As stated above, activation of AMPK results in increased oxidation of acyl-CoA. Adipo R1 and adipo R2 adiponectin receptors have been identified and cloned recently in myocytes and the liver, respectively, and expression of adipo R1 is associated with an increase in the activity of AMPK, ACC and p38 mitogen-activated protein kinase (MAPK), whereas in hepatocytes there is an increase in the phosphorylation of AMPK and ACC; adiponectin also increases the activity of PPAR-a, a transcription factor playing a key role in the regulation of fatty acid oxidation.
8 Figure 2 shows a model for the mechanism of action of adiponectin in the regulation of fatty acid oxidation and insulin sensitivity.
Relationships between insulin, leptin and adiponectin and plasma lipids in prepubertal obese children
We have recently carried out a study in obese (n ¼ 34) and control (n ¼ 20) prepubertal children to determine the potential relationships between insulin, leptin and adiponectin and plasma lipids. Plasma TGs as well as apo-B levels were significantly higher in obese than in controls (Po0.001). However, cholesterol was slightly lower in the obese group. Moreover, HDL-c levels were significantly reduced in obese children compared with the control group. However, no major differences were observed for apo-A-I. Insulin and leptin were markedly higher in the obese group who developed an insulin resistance pattern, whereas adiponectin was significantly reduced compared with the control children.
A high positive and significant correlation was observed between insulin and TGs and apo-B plasma levels, whereas the correlation was negative for HDL-c. The same pattern was observed for the relationships between leptin and plasma lipids, except that no correlation was found for leptin and apo-B. By contrast, adiponectin plasma concentrations correlated negatively with TGs and apo-B and positively with HDL-c. Absolute values for the correlations between adiponectin and plasma lipids were higher than those obtained for insulin and leptin (Table 1) . 
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Hormones and plasma lipids M Gil-Campos et al
Insulin and leptin were positively correlated, whereas insulin and adiponectin showed a negative association (Figure 3 ). Adiponectin and leptin were also negatively correlated, but the association was relatively weak (r ¼ À0.368; P ¼ 0.014).
Although leptin is related to the control of body composition and energy expenditure in animals and humans, the tissue resistance observed in obese subjects explains the observed high plasma levels of leptin without a concomitant inhibition of food intake. 4, 12 In our study, leptin plasma concentrations were positively associated to anthropometric markers of fat mass and also to basal energy expenditure, which corroborates that, also in prepubertal children, leptin resistance is markedly evident. Leptin has been shown to be associated to insulin by other investigators in childhood and adult life. 5, 29 However, in the present study, only a weak correlation was found between leptin and adiponectin, suggesting that the association between these two hormones is more a consequence of adiposity than a cause-effect relationship in the development of insulin resistance. Insulin resistance and an altered plasma lipid pattern are common pathophysiological features of the metabolic syndrome not only in adults but also in childhood and adolescence. 10, 11 However, the etiology of insulin resistance and its associated biochemical alterations, particularly those affecting lipid metabolism, continue to be a matter of debate.
Adiponectin seems to be the missing link between insulin resistance and the alterations observed in plasma lipids. In the present study, obese children exhibited a marked hyperinsulinemia, which was positively associated with plasma lipid markers of cardiovascular disease and metabolic syndrome, that is, high levels of TGs and apo-B, but negatively associated with HDL-c and plasma adiponectin concentrations. Those associations were similar to or higher than those observed for insulin. Moreover, insulin and Hormones and plasma lipids M Gil-Campos et al adiponectin were highly but negatively correlated. From these results, we suggest that adiponectin may have a direct impact in the regulation of insulinemia as well as in lipoprotein metabolism, confirming that, not only in adults but also in prepubertal children, insulin and adiponectin are antagonist hormones reciprocally regulated. Low levels of adiponectin would decrease the interaction with its hepatic and skeletal muscle receptors and contribute to downregulate the insulin transduction signal cascade, resulting in a reduced fatty acid oxidation, activation of hepatic gluconeogenesis and reduced glucose uptake in both tissues. Hormones and plasma lipids M Gil-Campos et al
